British Journal of Ophthalmology · 1997 · 56 citations · 9 references
MedicineInfectious DiseasesOphthalmologyOcular DiseaseOphthalmic EpidemiologyVisual DisordersBlindness EpidemiologyGlaucomaVision ImpairmentVisual ImpairmentVisual Impairment EpidemiologyAvoidable BlindnessAvoidable Visual ImpairmentCauses Of BlindnessGlaucoma BlindnessIncidence Of Visual ImpairmentIvermectin TreatmentOnchocerciasis-related BlindnessPreventable Blindness
AIMS: A population based survey of blindness and visual impairment was conducted in the district of Bossangoa, Central African Republic. METHODS: A total of 48 communities were randomly selected, and 6086 people examined. RESULTS: The prevalence of blindness (visual acuity in the better eye less than 3/60) was 2.2%, and visual impairment 3.0% (6/24 to 3/60 in the better eye). The major causes of blindness were onchocerciasis (73.1%), cataract (16.4%), trachoma (4.5%), and glaucoma (2.2%). CONCLUSION: Around 95.5% of all blindness could potentially have been prevented or treated. Ivermectin mass distribution is hoped to prevent 50% of all forms of visual loss in the future.
9
Khalid F. Tabbarra · Annals of Saudi Medicine · 1996 · 173 citations
Life Sciences, Biology, Microbiology +15
Betty Kirkwood, Peter G. Smith, Tom Marshall et al. · Transactions of the Royal Society of Tropical Medicine and Hygiene · 1983 · 81 citations
Medicine, Infectious Disease Control, Infectious Diseases +15
1989 World Health Statistics Annual
Trends in Food Science & Technology · 1990 · 70 citations
WHO expert committee on onchocerciasis
K. Awadzi, DW Buttner, R. Garms et al. · 1987 · 60 citations